Nadège Pelletier
2023
In 2023, Nadège Pelletier earned a total compensation of $1.7M as Chief Scientific Officer at Barinthus Biotherapeutics plc..
Compensation breakdown
| Non-Equity Incentive Plan | $140,867 |
|---|---|
| Option Awards | $1,114,349 |
| Salary | $382,791 |
| Other | $34,992 |
| Total | $1,672,999 |
Pelletier received $1.1M in option awards, accounting for 67% of the total pay in 2023.
Pelletier also received $140.9K in non-equity incentive plan, $382.8K in salary and $35K in other compensation.
Rankings
In 2023, Nadège Pelletier's compensation ranked 680th out of 3,006 executives tracked by ExecPay. In other words, Pelletier earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 680 out of 3,006 | 77th |
Division Manufacturing | 384 out of 1,650 | 77th |
Major group Chemicals And Allied Products | 262 out of 918 | 72nd |
Industry group Drugs | 258 out of 881 | 71st |
Industry Pharmaceutical Preparations | 164 out of 637 | 74th |
Source: SEC filing on March 22, 2024.
Pelletier's colleagues
We found two more compensation records of executives who worked with Nadège Pelletier at Barinthus Biotherapeutics plc. in 2023.